Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

The patient has Chronic Cutaneous Lupus, a skin condition causing plaques and hair loss.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Lichen planopilaris may have a genetic link.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Linear cutaneous lupus erythematosus on the scalp is rare, often affects young Asians, and can be treated with specific medications.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Both environmental and genetic factors contribute to Lichen Planopilaris.

Wearing fire helmets may worsen lichen planopilaris in firefighters.

Two patients had a rare combination of red skin spots and white scaly skin lesions not on the genitals.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Imatinib can cause hair loss due to lichen planopilaris.